136 Summit Avenue
Montvale, NJ 07645
United States
201 351 0605
https://www.eompharma.com
Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 3
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Dr. Irach B. Taraporewala B.S., M.S., Ph.D. | CEO, President & Director | 265.65k | N/A | 1956 |
Mr. Wayne I. Danson CPA | CFO & Treasurer | 150k | N/A | 1954 |
Mr. Eli Goldberger | Founder, Chairman & COO | N/A | N/A | 1990 |
Dr. Shalom Z. Hirschman M.D. | Co-Founder, Chief Scientific Officer & Medical Director | N/A | N/A | 1936 |
Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. Immunocellular Therapeutics, Ltd. was founded in 2020 and is headquartered in Montvale, New Jersey.
EOM Pharmaceuticals Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.